Lymphatic vessels and tertiary lymphoid organs.

Area of Science:

• Immunology
• Vascular Biology

Background:

• Tertiary lymphoid organs (TLOs) are lymphoid cell aggregates in chronic inflammation.
• TLOs share structural similarities with lymph nodes, including high endothelial venules and lymphatic vessels (LVs).
• While acute inflammation can impair LVs, TLO LVs maintain functionality.

Purpose of the Study:

• To investigate the function and molecular regulation of lymphatic vessels (LVs) within tertiary lymphoid organs (TLOs).
• To compare the molecular mechanisms of TLO LV development with canonical lymphangiogenesis.
• To explore the therapeutic implications of TLO LV research.

Main Methods:

• Analysis of cellular content and organization within TLOs.
• Assessment of fluid drainage and cell transport capabilities of TLO LVs.
• Investigation of molecular regulators, including cytokines and hematopoietic cells, involved in TLO LV development.

Main Results:

• TLO LVs demonstrate normal function in fluid drainage and cell trafficking in response to chemokine and sphingosine-1-phosphate (S1P) gradients.
• The molecular regulation of TLO LVs diverges from developmental lymphangiogenesis, relying on cytokines and hematopoietic cells.
• TLO LVs exhibit unique characteristics compared to LVs formed during ontogeny.

Conclusions:

• Lymphatic vessels in tertiary lymphoid organs are functional and possess distinct regulatory mechanisms.
• Elucidating the molecular control of TLO LVs provides insights into potential therapies for lymphedema, autoimmunity, and cancer.
• Further research into TLO LVs is crucial for advancing treatments in diverse inflammatory and immune-related conditions.